Enjoy complimentary customisation on priority with our Enterprise License!
The global effervescent tablet market size is estimated to grow by USD 4.80 billion, at a CAGR of 8.36% between 2023 and 2028. Effervescent tablets are a good alternative to regular tablets for people who have difficulty swallowing due to illness or aging. Older people may have difficulty swallowing tablets but need to take medications or supplements regularly. Swallowing effervescent tablets is much simpler than swallowing a regular tablet. It is also a good way of swallowing medicine for people with sore throats or other medical conditions that make it difficult to swallow, making it a good alternative to regular tablets. Furthermore, effervescent pills provide immediate relief from any medical condition due to their uniform mixing in the water. It can be used to treat any medical condition based on its run time. Most importantly, it can heal disorders in a short period, as opposed to conventional medication, which takes a longer time to be digested by the body.
To learn more about this report, Download Report Sample
The market share growth by the hospital pharmacy segment will be significant during the forecast period. The increasing prevalence and diagnosis of diseases such as flue and gastrointestinal diseases and the increasing number of public and private specialty hospitals and clinics providing tablets will influence the growth of the hospital pharmacy segment in this market.
Get a glance at the market contribution of various segments Download PDF Sample
The hospital pharmacy segment was the largest and was valued at USD 3.89 billion in 2018. Large hospitals and clinics are equipped with advanced medical infrastructure and procure high-quality medical products and consumables in bulk. Other factors that are positively influencing segmental growth include an increase in admissions of patients with symptoms such as headache, nausea, vomiting, photophobia, and phonophobia, which can increase the demand. As a result, the availability of efficient treatment and the increase in the number of patients visiting hospitals and clinics during the forecast period. Therefore, all such features will drive the growth of the hospital pharmacy segment in the market during the forecast period.
A prescription drug is a medication that can only be prescribed to a patient under the written instructions of a licensed medical practitioner. Some examples of prescription drugs include blood pressure pills, cancer drugs, and powerful painkillers. A drug is considered a prescription drug because of several factors such as the safety of the product, the route of administration (e.g., injection), and the risk of drug abuse. The increasing prevalence of chronic diseases, rising number of patient visits to physicians, and increasing healthcare expenditure by individuals are likely to boost the growth of the prescription segment in the market during the forecast period.
For more insights about the market share of various regions Download PDF Sample now!
North America is estimated to contribute 41% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional market growth and trends, and drivers that will shape the market during the forecast period. The market in North America is primarily driven by the demand for multivitamins and supplement tablets in the US, followed by Canada and Mexico. Consumers in developed countries in North America have a greater interest in a healthy diet due to the better awareness of the nutritional content of food products and the large-scale promotional activities undertaken by effervescent pills manufacturers, trade organizations, and medical institutions about the potential benefits of following a healthy diet. Further, the consumption of tablets in the region is expected to increase due to a significant rise in the demand for dietary and nutritional food products among millennials.
In addition, consumers in North America are more inclined toward organic and natural dietary products that supplement natural nutrients, and this preference has spurred the consumption of herbal and plant-based effervescent pills. Consumers in the region prefer to procure effervescent pills through online distribution channels, as this helps them compare products and their properties before making a decision. Internet and smartphone penetration is high in North America, which has increased the adoption of e-commerce for buying tablets. Such factors are expected to drive the regional market growth during market growth.
Buy Full Effervescent Tablet Market Size Analysis Report Now
The effervescent tablet market overview report is driven by the increasing demand for dietary supplements, offering benefits for overall health. However, high production costs pose challenges for producers. Specialized equipment is needed for precise ingredient control during manufacturing processes such as granulation, mixing, tablet compression, and packing. Additional packaging needs and quality control add to expenses. Despite these challenges, effervescent tablets are gaining popularity due to their advantages over conventional tablets and capsules. Effervescent tablets offer additional processing steps like effervescent reaction and quick tablet disintegration, appealing to various demographic groups seeking vitamins, minerals, and other health supplements. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges.
The rising prevalence of chronic diseases is a major driver. Effervescent pills are gaining popularity as they are convenient for physicians and patients alike. A sedentary lifestyle negatively affects the homeostasis of the body, making people susceptible to many illnesses, such as allergic conditions (cold, flu), chronic pain, and many more chronic diseases. Treatment of all these diseases has become critical, leading to hospitalization. Among chronic pain, migraine is the leading illness. According to the Migraine Research Foundation, migraines impact the health of more than 39 million US citizens every year.
Moreover, chronic respiratory diseases rank as 3rd most common cause of death. According to the National Center for Chronic Disease Prevention and Health Promotion, around 15.7 million Americans had chronic obstructive pulmonary disease (COPD) in 2021. These chronic illnesses require quick and convenient drug formulation. Individuals are choosing effervescent pills to treat chronic illnesses.
The development of organic effervescent tablets is an emerging market trend. Most times effervescent pills are manufactured with ingredients synthetically derived that can interfere with tastes and fear of high sodium intake in some cases, which leads to a reduction in the adoption. However, the development of organic effervescent tablets might overcome the hurdle of traditional tablets.
For instance, effervescent pills prepared by the introduction of a significant amount of neem oil instead of silica and the use of potassium citrate offer the benefits of organic flavor and no risk of high sodium ingestion, which further increases the growth of the market during the forecast period.
Side effects of effervescent tablets are a significant challenge hindering market growth. Tablets that quickly dissolve in water or another liquid and release carbon dioxide are known as effervescent pills. These tablets help quick therapeutic results for chronic illnesses such as migraine, headaches, hyperacidity, and allergies. However, effervescent tablets are prohibited in the majority of chronic diseases such as diabetes and asthma. Owing to the high sodium content in effervescent tablets might cause blood pressure issues in diabetic patients and muscle cramping after administration of effervescent pills might further worsen asthma in patients.
In addition, effervescent pills can cause further trouble if the patients are consuming opioid analgesics, antihistamines, and muscle relaxants. Tablets can cause trouble in breathing, dizziness, and nausea, which might disrupt patient compliance to the tablets, which might decline the growth of the market during the forecast period.
Buy Now Full effervescent tablet market size analysis report
The market growth analysis report includes the adoption lifecycle of the market research and growth, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth and forecasting strategies.
Effervescent Tablet Market Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The market analysis and report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
Alturix Ltd. - The company offers phosphate Sandoz.
In this effervescent tablet market overview report qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market is witnessing significant growth in pharmaceuticals, catering to various administration routes such as oral, nasal, topical, and injectable. This expansion is fueled by an aging population, swallowing difficulties, and capsule compliance issues, particularly among children and the elderly. With a promising growth rate and increasing market value, market segments are diversifying, with extensive geographical coverage. Expert analysis indicates a dynamic market scenario, focusing on patient epidemiology, pipeline analysis, and pricing analysis within the regulatory framework. Effervescent pills offer a convenient solution for chronic patients, promoting health awareness and supplementing disposable income. They encompass diverse formulations, including glucose tablets, probiotics, minerals, and dietary supplements, addressing a range of health issues like high blood pressure, cardiovascular disorders, and heart strokes, through innovative R&D activities and novel medications, while minimizing plastic usage and leveraging sodium bicarbonate for fizzing, bubbling, and rapid dissolution. The global effervescent tablet market faces challenges such as high production cost, which include expenses for raw ingredients, personnel, and the manufacturing process, as highlighted in the journal 'Pharmaceuticals'.
The market is set for growth, driven by the increasing focus on overall health and wellness. However, there are several market restraints such as high production costs, the need for specialized equipment, and additional packaging needs. Despite these challenges, there are significant market opportunities for producers, especially in catering to specific demographic groups and the demand for vitamins and minerals. Effervescent tablets require precise ingredient control and undergo various manufacturing processes like granulation, tablet compression, and packing. Quality control and regulatory compliance are essential due to the unique characteristics of effervescent tablets, including effervescent reaction and tablet disintegration. The market is dynamic, with solid dosage forms like conventional tablets and capsules undergoing additional processing steps to meet consumer demands. There is another segment for weight loss medications and newer versions of apple cider vinegar tablets that are now being formulated as effervescent tablets.
The effervescent tablet market analysis report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in USD Billion for the period 2024 to 2028, as well as historical data from 2018 to 2023 for the following segments.
Effervescent Tablet Market Scope |
|
Report Coverage |
Details |
Page number |
159 |
Base year |
2023 |
Historic period |
2018-2022 |
Market forecasting period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 8.36% |
Market Growth 2024-2028 |
USD 4.80 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
7.84 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 41% |
Key countries |
US, Germany, UK, India, and Japan |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks, effervescent tablet industry share |
Key companies profiled |
Alturix Ltd., Bayer AG, Bliss GVS Pharma Ltd., Bristol Myers Squibb Co., CHIESI Farmaceutici SpA, GlaxoSmithKline Plc, Herbalife International of America Inc., HERMES PHARMA GmbH, Natur Produkt Zdrovit Sp Z O O, Nestle SA, Novartis AG, Perrigo Co. Plc, Pfizer Inc., Reckitt Benckiser Group Plc, SciTech Specialities Pvt Ltd., Strava Healthcare Pvt. Ltd., S. G. Biopharm Pvt. Ltd., Swisse Wellness Pty Ltd., Vitabiotics Ltd., and Vovantis Laboratories |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period, effervescent tablet market share. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
We can help! Our analysts can customize this effervescent tablet market worth report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Distribution Channel
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.